Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix

Clinical and Experimental Immunology

Volumn 111, Issue 1, 1998, Pages 219-224

  Jacobs, N ^a,b   Giannini, S L ^a   Doyen, J ^a   Baptista, A ^a   Moutschen, M ^a   Boniver, J ^a   Delvenne, P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Blood culture; Cervical squamous intraepithelial lesion; Human papillomavirus; IL 10; IL 12

Indexed keywords

CD3 ANTIGEN; CD69 ANTIGEN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4;

ADULT; ARTICLE; BLOOD LEVEL; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MONONUCLEAR CELL; PRECANCER; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; WART VIRUS;

ADULT; BIOLOGICAL MARKERS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; UTERINE CERVICAL NEOPLASMS;

EID: 0031882933     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00437.x     Document Type: Article

References (45)

1. Wu T-C, Kurman RJ. Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms. J Natl Cancer Inst 1997; 89:185-7.
2. NCI Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1989; 262:931-4.
3. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87:796-802.
4. Benton C, Shahidullah H, Hunter JAA. Human papillomavirus in the immunosuppressed. Papillomavirus Rep 1992; 3:23-26.
5. Petry KU, Scheffel D, Bode U et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994; 57:836-40.
6. Wu TC. Immunology of the human papilloma virus in relation to cancer. Curr Opin Immunol 1994; 6:746-54.
7. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1,Th2 and more. Immunol Today 1996; 17:138-46.
8. Scott P. IL-12: initiation cytokine for cell-mediated immunity. Sciences 1993; 260:496-7.
9. Pisa P, Halapi E, Pisa EK et al. Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 1992; 89:7708-12.
10. Clerici M, Ferrario E, Trabattoni D et al. Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease. Eur J Cancer 1994; 30A:1464-70.
11. Huang M, Wang J, Lee P et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 1995; 55:3847-53.
12. Huettner C, Paulus W, Roggendorf W. Messenger RNA expression of the immunosuppressive cytokine Il-10 in human gliomas. Am J Pathol 1995; 146:317-22.
13. Krüger-Krasagakes S, Krasagakis K, Garbe C et al. Expression of interleukin 10 in human melanoma. Br J Cancer 1994; 70:1182-5.
14. Levy S, Kopersztych S, Musatti CC, Souen JS, Salvatore CA, Mendes NF. Cellular immunity in squamous cell carcinoma of the uterine cervix. Am J Obstet Gynecol 1978; 130:160-4.
15. Kono K, Ressing ME, Brandt RMP et al. Decreased expression of signal-transducing ζ chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 1996; 2:1825-8.
16. Elsässer-Beile U, von Kleist S, Sauther W, Gallati H, Schulte Mönting J. Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages. Br J Cancer 1993; 68:32-36.
17. Clerici M, Merola M, Ferrario E et al. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 1997; 89:245-50.
18. Davies DH, Stauss HJ. The significance of human leukocyte antigen associations with cervical cancer. Papillomavirus Report 1997; 8:43-50.
19. Ashton-Rickardt PG, Bandeira A, Delaney JR et al. Evidence for differential avidity model of T cell selection in the thymus. Cell 1994; 76:651-63.
20. Jacobs MV, De Rodo Husman AM, Van den Bruck AJC, Snijders PJF, Meijer CJLM, Walboomer JMM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995; 33:901-5.
21. De Groote D, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1β,TNF-α, IL-6, IL-2, IFN-γ, and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992; 4:239-48.
22. Terstappen LWMM, Buescher S, Nguyen M, Reading C. Differentiation and maturation of growth factor expanded human hematopoietic progenitors assessed by multidimensional flow cytometry. Leukemia 1992; 6:1001-10.
23. Jacobs N, Moutschen MP, Boniver J, Greimers R, Schaaf-Lafontaine N. Efficient immunoselection of cytolytic effectors with a magnetic cell sorter. Res Immunol 1993; 144:141-50.
24. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A,-B,-C and -D antigens. Am J Clin Pathol 1978; 69:103-20.
25. Buyse I, Decorte R, Cuppens H et al. Rapid DNA typing of class II HLA antigen using polymerase chain reaction and reverse dot blot hybidization. Tissue Antigens 1993; 41:1-14.
26. Baur MP. Histocompatibility testing. Berlin: Springer-Verlag, 1984.
27. Koch F, Stanzl U, Jennewein P et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 1996; 184:741-6.
28. Nakagomi H, Pisa P, Pisa EK et al. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int J Cancer 1995; 63:366-71.
29. 2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J Immunol 1996; 157:5512-20.
30. Kim J, Moldin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, Uyemura K. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol 1995; 155:2240-7.
31. + cytotoxic T lymphocytes from tumor-infiltrating lymphocytes. Jpn J Cancer Res 1995; 86:135-9.
32. Tahara H, Zeh IIIHJ, Storkus WJ et al. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 1994; 54:182-9.
33. Yu W-G, Yamamoto N, Takenaka H et al. Molecular mechanisms underlying IFN-γ-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12. Int Immunol 1996; 8:855-65.
34. Chehimi J, Starr SE, Frank I et al. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994; 179:1361-6.
35. Orange JS, Wang B, Terhost C, Biron CA. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 1996; 156:1138-42.
36. Viscidi RP, Kotloff KL, Clayman B, Russ K, Shapiro S, Shah KV. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among College women. Clin Diagn Lab Immunol 1997; 4:122-6.
37. Tsuki T, Hildesheim A, Schiffman MH et al. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res 1996; 56:3967-74.
38. McKee WD, Arnold CA, Perlman MD. A double-blind study of comparative incidence of malignancy and allergy. J Allergy 1967; 39:294-301.
39. Vandenvelde C, De Foor M, Van Beers D. HLA-DQB1*03 and cervical intraepithelial neoplasia grades I-III. Lancet 1993; 341:442-3.
40. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet 1994; 6:157-62.
41. Gregoire L, Lawrence WD, Kukuruga D, Eisenbrey AB, Lancaster WB. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer 1994; 57:504-7.
42. Sastre-Garau X, Loste M-N, Vincent-Salomon A et al. Decreased frequency of HLA-DRB1*13 alleles in French women with HPV-positive carcinoma of the cervix. Int J Cancer 1996; 69:159-64.
43. Woodworth CD, Simpson S. Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines. Am J Pathol 1993; 56:3967-74.
44. Malejczyk J, Malejczyk M, Urbanski A et al. Constitutive release of IL6 by human papillomavirus type 16 (HPV16)-harboring keratinocytes: a mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells. Cell Immunol 1991; 136:155-64.
45. Tatour E, Gey A, Sastre-Garau X et al. Analysis of interleukin 6 expression in cervical neoplasia using a quantative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Res 1994; 54:6243-8.